back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-03-27 17:41 Tx date 2024-03-27 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,567
+4,211 vol $1.56 each |
248,818 | |
| Filed 2024-03-27 17:40 Tx date 2024-03-27 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$78.50
+50 vol $1.57 each |
244,607 | |
| Filed 2024-03-27 17:39 Tx date 2024-03-27 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,152
+739 vol $1.56 each |
244,557 | |
| Filed 2024-03-27 10:26 Tx date 2024-03-26 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,554
+3,000 vol $1.52 each |
243,818 | |
| Filed 2024-03-27 10:25 Tx date 2024-03-25 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,538
+1,000 vol $1.54 each |
240,818 | |
| Filed 2024-03-25 10:02 Tx date 2024-03-22 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,469
+3,000 vol $1.49 each |
239,818 | |
| Filed 2024-03-22 15:30 Tx date 2024-03-21 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,140
+3,000 vol $1.38 each |
236,818 | |
| Filed 2024-03-22 15:29 Tx date 2024-03-21 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,000
+5,000 vol $1.40 each |
233,818 | |
| Filed 2024-03-22 15:28 Tx date 2024-03-21 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,408
+1,000 vol $1.41 each |
228,818 | |
| Filed 2024-01-09 11:59 Tx date 2023-12-08 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$20,000
+20,000 vol $1.00 each |
225,818 | |
| Filed 2023-12-27 11:19 Tx date 2023-12-08 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$20,000
+20,000 vol $1.00 each |
||
| Filed 2023-12-27 11:19 Tx date 2023-12-08 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$20,000
+20,000 vol $1.00 each |
225,818 | |
| Filed 2023-12-21 09:39 Tx date 2023-12-20 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,698
+2,000 vol $1.35 each |
207,818 | |
| Filed 2023-11-03 13:54 Tx date 2023-11-01 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,066
+1,000 vol $2.07 each |
205,818 | |
| Filed 2023-10-26 15:05 Tx date 2023-10-23 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,115
+900 vol $1.24 each |
204,818 | |
| Filed 2023-10-26 15:03 Tx date 2023-10-23 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$123.00
+100 vol $1.23 each |
203,918 | |
| Filed 2023-10-26 15:02 Tx date 2023-10-23 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$123.10
+100 vol $1.23 each |
203,818 | |
| Filed 2023-10-26 15:01 Tx date 2023-10-23 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$123.00
+100 vol $1.23 each |
203,718 | |
| Filed 2023-10-26 15:00 Tx date 2023-10-23 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$123.00
+100 vol $1.23 each |
203,618 | |
| Filed 2023-10-26 15:00 Tx date 2023-10-23 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$246.00
+200 vol $1.23 each |
203,518 | |
| Filed 2023-10-26 14:58 Tx date 2023-10-23 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$123.00
+100 vol $1.23 each |
203,118 | |
| Filed 2023-10-26 14:56 Tx date 2023-10-23 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$123.00
+100 vol $1.23 each |
203,018 | |
| Filed 2023-10-26 14:55 Tx date 2023-10-23 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$123.00
+100 vol $1.23 each |
202,918 | |
| Filed 2023-10-19 11:48 Tx date 2023-10-16 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,320
+1,000 vol $1.32 each |
202,818 | |
| Filed 2023-09-25 09:44 Tx date 2023-09-22 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,980
+1,000 vol $1.98 each |
201,818 | |
| Filed 2023-09-18 11:25 Tx date 2023-09-18 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,890
+1,000 vol $1.89 each |
200,818 | |
| Filed 2023-06-01 14:57 Tx date 2023-05-22 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$298.27
+100 vol $2.98 each |
199,818 | |
| Filed 2023-06-01 14:56 Tx date 2023-05-22 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,516
+850 vol $2.96 each |
199,718 | |
| Filed 2023-04-04 14:27 Tx date 2023-04-03 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$516.00
+200 vol $2.58 each |
198,868 | |
| Filed 2023-04-04 14:26 Tx date 2023-04-03 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$518.00
+200 vol $2.59 each |
198,668 | |
| Filed 2023-04-04 14:24 Tx date 2023-04-03 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$633.60
+240 vol $2.64 each |
198,468 | |
| Filed 2023-04-03 09:12 Tx date 2023-03-30 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,872
+1,000 vol $2.87 each |
198,228 | |
| Filed 2023-03-28 10:08 Tx date 2023-03-27 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$672.75
+230 vol $2.92 each |
197,228 | |
| Filed 2023-03-28 10:07 Tx date 2023-03-22 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,251
+400 vol $3.13 each |
196,998 | |
| Filed 2023-03-28 10:07 Tx date 2023-03-20 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$334.00
+100 vol $3.34 each |
196,598 | |
| Filed 2023-03-20 10:05 Tx date 2023-03-17 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$968.46
+300 vol $3.23 each |
196,498 | |
| Filed 2023-03-20 10:04 Tx date 2023-03-17 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$650.00
+200 vol $3.25 each |
196,198 | |
| Filed 2023-03-20 10:02 Tx date 2023-03-17 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$482.89
+150 vol $3.22 each |
195,998 | |
| Filed 2023-02-26 01:10 Tx date 2023-02-19 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
$1,231,853
+300,452 vol $4.10 each |
700,452 | |
| Filed 2023-02-26 01:06 Tx date 2023-02-19 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
$1,231,853
+300,452 vol $4.10 each |
||
| Filed 2023-02-22 23:13 Tx date 2023-02-17 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$483.00
+120 vol $4.03 each |
195,848 | |
| Filed 2023-02-22 23:12 Tx date 2023-02-17 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$408.00
+100 vol $4.08 each |
195,728 | |
| Filed 2023-02-10 23:59 Tx date 2023-02-07 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$199,308
+84,812 vol $2.35 each |
195,628 | |
| Filed 2023-02-10 23:59 Tx date 2023-02-07 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
51 - Exercise of options
|
$-329,000
-140,000 vol $2.35 each |
400,000 | |
| Filed 2023-02-10 23:53 Tx date 2023-02-07 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$199,308
+84,812 vol $2.35 each |
||
| Filed 2023-02-10 23:51 Tx date 2023-02-07 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$199,308
+84,812 vol $2.35 each |
||
| Filed 2022-12-19 10:24 Tx date 2022-12-16 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,401
+490 vol $4.90 each |
110,816 | |
| Filed 2022-12-19 10:23 Tx date 2022-12-16 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,550
+510 vol $5.00 each |
110,326 | |
| Filed 2022-12-19 10:21 Tx date 2022-12-16 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,915
+1,000 vol $4.92 each |
109,816 | |
| Filed 2022-11-08 11:53 Tx date 2022-11-04 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$966.00
+200 vol $4.83 each |
108,816 | |
| Filed 2022-11-08 11:52 Tx date 2022-11-03 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$471.00
+100 vol $4.71 each |
108,616 | |
| Filed 2022-11-08 11:52 Tx date 2022-11-03 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$473.00
+100 vol $4.73 each |
108,516 | |
| Filed 2022-11-08 10:55 Tx date 2022-11-08 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$966.00
+200 vol $4.83 each |
108,816 | |
| Filed 2022-11-08 10:55 Tx date 2022-11-08 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$966.00
+200 vol $4.83 each |
||
| Filed 2022-11-08 10:54 Tx date 2022-11-07 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$471.00
+100 vol $4.71 each |
108,616 | |
| Filed 2022-11-08 10:54 Tx date 2022-11-07 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$471.00
+100 vol $4.71 each |
||
| Filed 2022-11-08 10:53 Tx date 2022-11-07 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$473.00
+100 vol $4.73 each |
||
| Filed 2022-11-08 10:53 Tx date 2022-11-07 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$473.00
+100 vol $4.73 each |
108,516 | |
| Filed 2022-10-06 12:51 Tx date 2022-09-29 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$783.82
+200 vol $3.92 each |
108,416 | |
| Filed 2022-10-06 12:46 Tx date 2022-09-28 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$391.00
+100 vol $3.91 each |
107,016 | |
| Filed 2022-10-06 12:43 Tx date 2022-09-27 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,454
+600 vol $4.09 each |
106,916 | |
| Filed 2022-10-06 12:43 Tx date 2022-09-27 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,636
+400 vol $4.09 each |
106,316 | |
| Filed 2022-10-06 12:42 Tx date 2022-09-29 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$783.82
+200 vol $3.92 each |
||
| Filed 2022-10-06 12:42 Tx date 2022-09-29 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$389.00
+100 vol $3.89 each |
108,216 | |
| Filed 2022-10-06 12:41 Tx date 2022-09-29 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$388.90
+100 vol $3.89 each |
108,116 | |
| Filed 2022-10-06 12:41 Tx date 2022-09-29 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$385.00
+100 vol $3.85 each |
108,016 | |
| Filed 2022-10-06 12:40 Tx date 2022-09-29 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$388.27
+100 vol $3.88 each |
107,916 | |
| Filed 2022-10-06 12:40 Tx date 2022-09-29 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,166
+300 vol $3.89 each |
107,816 | |
| Filed 2022-10-06 12:39 Tx date 2022-09-29 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,156
+300 vol $3.85 each |
107,516 | |
| Filed 2022-10-06 12:38 Tx date 2022-09-29 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$789.80
+200 vol $3.95 each |
107,216 | |
| Filed 2022-09-26 11:03 Tx date 2022-09-23 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$72.00
+18 vol $4.00 each |
105,916 | |
| Filed 2022-09-26 11:02 Tx date 2022-09-23 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$992.20
+242 vol $4.10 each |
105,898 | |
| Filed 2022-09-26 11:02 Tx date 2022-09-23 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$237.80
+58 vol $4.10 each |
105,656 | |
| Filed 2022-09-26 11:01 Tx date 2022-09-23 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$410.00
+100 vol $4.10 each |
105,598 | |
| Filed 2022-09-26 11:01 Tx date 2022-09-23 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$410.00
+100 vol $4.10 each |
105,498 | |
| Filed 2022-09-26 11:00 Tx date 2022-09-23 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$891.00
+220 vol $4.05 each |
105,398 | |
| Filed 2022-09-26 11:00 Tx date 2022-09-23 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,134
+280 vol $4.05 each |
105,178 | |
| Filed 2022-09-26 10:59 Tx date 2022-09-23 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$420.00
+100 vol $4.20 each |
104,898 | |
| Filed 2022-09-26 10:59 Tx date 2022-09-23 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,980
+1,900 vol $4.20 each |
104,798 | |
| Filed 2022-09-26 10:58 Tx date 2022-09-23 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,315
+1,000 vol $4.32 each |
102,898 | |
| Filed 2022-09-26 10:56 Tx date 2022-09-23 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,182
+500 vol $4.36 each |
101,898 | |
| Filed 2022-09-26 09:56 Tx date 2022-09-20 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$503.05
+100 vol $5.03 each |
98,098 | |
| Filed 2022-09-26 09:56 Tx date 2022-09-22 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$149.76
+32 vol $4.68 each |
101,398 | |
| Filed 2022-09-26 09:55 Tx date 2022-09-22 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$318.24
+68 vol $4.68 each |
101,366 | |
| Filed 2022-09-26 09:55 Tx date 2022-09-22 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$459.99
+100 vol $4.60 each |
101,298 | |
| Filed 2022-09-26 09:54 Tx date 2022-09-22 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$395.59
+86 vol $4.60 each |
101,198 | |
| Filed 2022-09-26 09:54 Tx date 2022-09-22 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,456
+314 vol $4.64 each |
101,112 | |
| Filed 2022-09-26 09:53 Tx date 2022-09-22 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,314
+500 vol $4.63 each |
100,798 | |
| Filed 2022-09-26 09:53 Tx date 2022-09-22 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,277
+500 vol $4.55 each |
100,298 | |
| Filed 2022-09-26 09:52 Tx date 2022-09-22 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$458.90
+100 vol $4.59 each |
99,798 | |
| Filed 2022-09-26 09:52 Tx date 2022-09-22 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$458.97
+100 vol $4.59 each |
99,698 | |
| Filed 2022-09-26 09:51 Tx date 2022-09-22 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$459.00
+100 vol $4.59 each |
99,598 | |
| Filed 2022-09-26 09:51 Tx date 2022-09-22 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$459.00
+100 vol $4.59 each |
99,498 | |
| Filed 2022-09-26 09:50 Tx date 2022-09-22 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$459.00
+100 vol $4.59 each |
99,398 | |
| Filed 2022-09-26 09:50 Tx date 2022-09-22 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,327
+500 vol $4.65 each |
99,298 | |
| Filed 2022-09-26 09:49 Tx date 2022-09-22 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,329
+500 vol $4.66 each |
98,798 | |
| Filed 2022-09-26 09:48 Tx date 2022-09-21 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$500.00
+100 vol $5.00 each |
98,298 | |
| Filed 2022-09-26 09:47 Tx date 2022-09-21 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$503.34
+100 vol $5.03 each |
98,198 | |
| Filed 2022-09-16 11:02 Tx date 2022-09-15 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,456
+300 vol $4.85 each |
97,998 | |
| Filed 2022-09-16 11:02 Tx date 2022-09-15 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,489
+500 vol $4.98 each |
97,698 | |
| Filed 2022-09-16 11:01 Tx date 2022-09-15 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,486
+300 vol $4.96 each |
97,198 | |
| Filed 2022-09-16 11:01 Tx date 2022-09-15 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$279.87
+57 vol $4.91 each |
96,898 | |
| Filed 2022-09-16 11:01 Tx date 2022-09-15 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$702.13
+143 vol $4.91 each |
96,841 | |
| Filed 2022-09-16 11:00 Tx date 2022-09-15 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$493.00
+100 vol $4.93 each |
96,698 | |
| Filed 2022-09-16 11:00 Tx date 2022-09-15 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$493.00
+100 vol $4.93 each |
96,598 | |
| Filed 2022-09-16 10:59 Tx date 2022-09-15 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$746.64
+153 vol $4.88 each |
96,498 | |
| Filed 2022-09-16 10:59 Tx date 2022-09-15 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$229.36
+47 vol $4.88 each |
96,345 | |
| Filed 2022-09-16 10:58 Tx date 2022-09-15 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$863.76
+177 vol $4.88 each |
96,298 | |
| Filed 2022-09-16 10:58 Tx date 2022-09-15 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$112.24
+23 vol $4.88 each |
96,121 | |
| Filed 2022-09-16 10:57 Tx date 2022-09-15 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$976.00
+200 vol $4.88 each |
96,098 | |
| Filed 2022-09-16 10:57 Tx date 2022-09-15 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$499.00
+100 vol $4.99 each |
95,898 | |
| Filed 2022-09-16 10:56 Tx date 2022-09-15 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$844.98
+169 vol $5.00 each |
95,798 | |
| Filed 2022-09-16 10:56 Tx date 2022-09-15 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,434
+687 vol $5.00 each |
95,629 | |
| Filed 2022-09-16 10:55 Tx date 2022-09-15 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$220.00
+44 vol $5.00 each |
94,942 | |
| Filed 2022-08-18 16:24 Tx date 2022-08-17 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,915
+500 vol $5.83 each |
94,898 | |
| Filed 2022-08-18 16:23 Tx date 2022-08-17 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,149
+200 vol $5.75 each |
94,398 | |
| Filed 2022-08-18 16:23 Tx date 2022-08-16 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,085
+200 vol $5.43 each |
94,198 | |
| Filed 2022-08-18 16:22 Tx date 2022-08-16 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,074
+200 vol $5.37 each |
93,998 | |
| Filed 2022-08-16 14:44 Tx date 2022-08-10 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$479.50
+100 vol $4.79 each |
90,698 | |
| Filed 2022-08-16 14:43 Tx date 2022-08-10 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$479.50
+100 vol $4.79 each |
90,598 | |
| Filed 2022-08-16 14:43 Tx date 2022-08-10 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$479.50
+100 vol $4.79 each |
90,498 | |
| Filed 2022-08-16 14:42 Tx date 2022-08-10 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$479.50
+100 vol $4.79 each |
90,398 | |
| Filed 2022-08-16 14:41 Tx date 2022-08-10 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$484.00
+100 vol $4.84 each |
90,298 | |
| Filed 2022-08-16 14:41 Tx date 2022-08-10 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$484.00
+100 vol $4.84 each |
90,198 | |
| Filed 2022-08-16 14:41 Tx date 2022-08-10 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,407
+500 vol $4.82 each |
90,098 | |
| Filed 2022-08-16 14:40 Tx date 2022-08-10 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,420
+296 vol $4.80 each |
89,598 | |
| Filed 2022-08-16 14:39 Tx date 2022-08-10 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$979.20
+204 vol $4.80 each |
89,302 | |
| Filed 2022-08-16 14:39 Tx date 2022-08-10 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,463
+300 vol $4.88 each |
89,098 | |
| Filed 2022-08-16 14:38 Tx date 2022-08-12 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,410
+800 vol $5.51 each |
93,298 | |
| Filed 2022-08-16 14:38 Tx date 2022-08-12 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,096
+200 vol $5.48 each |
92,498 | |
| Filed 2022-08-16 14:37 Tx date 2022-08-12 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$549.99
+100 vol $5.50 each |
92,298 | |
| Filed 2022-08-16 14:37 Tx date 2022-08-12 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$550.00
+100 vol $5.50 each |
92,198 | |
| Filed 2022-08-16 14:36 Tx date 2022-08-12 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$66.00
+12 vol $5.50 each |
92,098 | |
| Filed 2022-08-16 14:36 Tx date 2022-08-12 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$484.00
+88 vol $5.50 each |
92,086 | |
| Filed 2022-08-16 14:35 Tx date 2022-08-12 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,668
+300 vol $5.56 each |
91,998 | |
| Filed 2022-08-16 14:35 Tx date 2022-08-12 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,347
+600 vol $5.58 each |
91,698 | |
| Filed 2022-08-16 14:34 Tx date 2022-08-12 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,210
+400 vol $5.53 each |
91,098 | |
| Filed 2022-08-16 14:33 Tx date 2022-08-15 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$529.50
+100 vol $5.29 each |
93,798 | |
| Filed 2022-08-16 14:32 Tx date 2022-08-15 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$534.10
+100 vol $5.34 each |
93,698 | |
| Filed 2022-08-16 14:31 Tx date 2022-08-15 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,071
+200 vol $5.36 each |
93,598 | |
| Filed 2022-08-16 14:30 Tx date 2022-08-15 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$545.56
+100 vol $5.46 each |
93,398 | |
| Filed 2022-08-11 10:07 Tx date 2022-08-09 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$435.21
+100 vol $4.35 each |
88,798 | |
| Filed 2022-08-11 10:06 Tx date 2022-08-09 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,304
+300 vol $4.35 each |
88,698 | |
| Filed 2022-08-11 10:05 Tx date 2022-08-09 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,686
+400 vol $4.22 each |
88,398 | |
| Filed 2022-08-11 10:04 Tx date 2022-08-09 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,224
+295 vol $4.15 each |
87,998 | |
| Filed 2022-08-11 10:03 Tx date 2022-08-09 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$20.95
+5 vol $4.19 each |
87,703 | |
| Filed 2022-08-08 09:50 Tx date 2022-08-04 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$816.00
+200 vol $4.08 each |
87,348 | |
| Filed 2022-08-08 09:49 Tx date 2022-08-05 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$607.50
+150 vol $4.05 each |
87,698 | |
| Filed 2022-08-08 09:49 Tx date 2022-08-05 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$403.23
+100 vol $4.03 each |
87,548 | |
| Filed 2022-08-08 09:48 Tx date 2022-08-05 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$402.50
+100 vol $4.03 each |
87,448 | |
| Filed 2022-08-04 11:40 Tx date 2022-08-03 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,604
+400 vol $4.01 each |
87,148 | |
| Filed 2022-08-04 11:39 Tx date 2022-08-03 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$796.00
+200 vol $3.98 each |
86,748 | |
| Filed 2022-08-04 11:39 Tx date 2022-08-03 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,009
+500 vol $4.02 each |
86,548 | |
| Filed 2022-08-04 11:38 Tx date 2022-08-02 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,660
+400 vol $4.15 each |
86,048 | |
| Filed 2022-08-04 11:37 Tx date 2022-08-02 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,269
+300 vol $4.23 each |
85,648 | |
| Filed 2022-08-04 11:36 Tx date 2022-08-02 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,275
+300 vol $4.25 each |
85,348 | |
| Filed 2022-08-04 11:35 Tx date 2022-08-02 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$425.00
+100 vol $4.25 each |
85,048 | |
| Filed 2022-08-04 11:35 Tx date 2022-08-01 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8.98
+2 vol $4.49 each |
84,948 | |
| Filed 2022-08-04 11:34 Tx date 2022-08-01 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$360.80
+88 vol $4.10 each |
84,946 | |
| Filed 2022-06-09 15:41 Tx date 2022-06-09 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures
36 - Conversion or exchange
|
-$35,000 vol |
$0 | |
| Filed 2022-06-09 15:23 Tx date 2022-06-09 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
$174,998
+41,176 vol $4.25 each |
84,858 | |
| Filed 2022-06-09 15:00 Tx date 2022-06-09 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
$174,998
+41,176 vol $4.25 each |
||
| Filed 2022-05-12 09:26 Tx date 2022-05-11 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$221.50
+50 vol $4.43 each |
43,682 | |
| Filed 2022-05-11 09:27 Tx date 2022-05-09 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$466.50
+100 vol $4.67 each |
43,632 | |
| Filed 2022-05-11 09:26 Tx date 2022-05-09 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,820
+600 vol $4.70 each |
43,532 | |
| Filed 2022-05-11 09:26 Tx date 2022-05-09 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$958.00
+200 vol $4.79 each |
42,932 | |
| Filed 2022-05-11 09:25 Tx date 2022-05-09 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$479.00
+100 vol $4.79 each |
42,732 | |
| Filed 2022-05-11 09:24 Tx date 2022-05-09 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4.80
+1 vol $4.80 each |
42,632 | |
| Filed 2022-05-11 09:24 Tx date 2022-05-09 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,435
+299 vol $4.80 each |
42,631 | |
| Filed 2022-05-09 10:28 Tx date 2022-05-05 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$542.00
+100 vol $5.42 each |
42,332 | |
| Filed 2022-05-09 10:27 Tx date 2022-05-05 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$352.79
+63 vol $5.60 each |
42,232 | |
| Filed 2022-05-09 10:26 Tx date 2022-05-05 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$336.00
+60 vol $5.60 each |
42,169 | |
| Filed 2022-05-09 10:25 Tx date 2022-05-05 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$332.10
+60 vol $5.54 each |
42,109 | |
| Filed 2022-05-09 10:22 Tx date 2022-05-04 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$507.85
+90 vol $5.64 each |
42,049 | |
| Filed 2022-05-03 11:47 Tx date 2022-04-28 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$418.52
+75 vol $5.58 each |
41,659 | |
| Filed 2022-05-03 11:45 Tx date 2022-04-29 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$556.96
+100 vol $5.57 each |
41,959 | |
| Filed 2022-05-03 11:44 Tx date 2022-04-29 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$554.33
+100 vol $5.54 each |
41,859 | |
| Filed 2022-05-03 11:43 Tx date 2022-04-29 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$553.00
+100 vol $5.53 each |
41,759 | |
| Filed 2022-05-03 11:42 Tx date 2022-04-29 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$418.52
+75 vol $5.58 each |
||
| Filed 2022-04-27 23:01 Tx date 2022-04-27 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,395
+250 vol $5.58 each |
41,584 | |
| Filed 2022-04-25 10:34 Tx date 2022-04-22 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,855
+500 vol $5.71 each |
41,334 | |
| Filed 2022-04-25 10:34 Tx date 2022-04-22 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$565.00
+100 vol $5.65 each |
40,834 | |
| Filed 2022-04-25 10:33 Tx date 2022-04-22 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$750.10
+130 vol $5.77 each |
40,734 | |
| Filed 2022-04-25 10:33 Tx date 2022-04-22 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$572.00
+100 vol $5.72 each |
40,604 | |
| Filed 2022-04-14 16:19 Tx date 2022-04-12 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,689
+300 vol $5.63 each |
40,504 | |
| Filed 2022-04-14 16:18 Tx date 2022-04-12 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$570.00
+100 vol $5.70 each |
40,204 | |
| Filed 2022-04-14 16:18 Tx date 2022-04-12 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,740
+300 vol $5.80 each |
40,104 | |
| Filed 2022-04-14 16:18 Tx date 2022-04-12 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$583.36
+100 vol $5.83 each |
39,804 | |
| Filed 2022-04-13 14:51 Tx date 2022-04-11 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,767
+300 vol $5.89 each |
39,704 | |
| Filed 2022-04-11 14:59 Tx date 2022-04-11 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,758
+300 vol $5.86 each |
39,404 | |
| Filed 2022-04-11 14:58 Tx date 2022-04-11 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,152
+200 vol $5.76 each |
39,104 | |
| Filed 2022-04-11 14:58 Tx date 2022-04-11 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,461
+600 vol $5.77 each |
38,904 | |
| Filed 2022-04-06 21:45 Tx date 2022-04-06 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,207
+390 vol $5.66 each |
38,304 | |
| Filed 2022-04-06 21:45 Tx date 2022-04-06 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,825
+500 vol $5.65 each |
37,914 | |
| Filed 2022-04-06 21:44 Tx date 2022-04-06 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$575.00
+100 vol $5.75 each |
37,414 | |
| Filed 2022-04-06 21:44 Tx date 2022-04-06 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,722
+300 vol $5.74 each |
37,314 | |
| Filed 2022-04-03 19:40 Tx date 2022-04-01 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$674.70
+130 vol $5.19 each |
37,014 | |
| Filed 2022-04-03 19:40 Tx date 2022-04-01 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,545
+300 vol $5.15 each |
36,884 | |
| Filed 2022-04-03 19:39 Tx date 2022-04-01 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$505.00
+100 vol $5.05 each |
36,584 | |
| Filed 2022-04-01 14:57 Tx date 2022-03-31 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,491
+300 vol $4.97 each |
36,484 | |
| Filed 2022-04-01 14:57 Tx date 2022-03-31 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$504.00
+100 vol $5.04 each |
36,184 | |
| Filed 2022-04-01 14:56 Tx date 2022-03-31 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$514.00
+100 vol $5.14 each |
36,084 | |
| Filed 2022-03-31 11:55 Tx date 2022-03-30 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,497
+300 vol $4.99 each |
35,984 | |
| Filed 2022-03-31 11:55 Tx date 2022-03-30 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$492.00
+100 vol $4.92 each |
35,684 | |
| Filed 2022-03-31 11:54 Tx date 2022-03-30 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,318
+1,300 vol $4.86 each |
35,584 | |
| Filed 2022-03-31 11:54 Tx date 2022-03-30 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,910
+600 vol $4.85 each |
34,284 | |
| Filed 2022-03-31 11:53 Tx date 2022-03-30 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,006
+1,300 vol $4.62 each |
33,684 | |
| Filed 2022-02-17 16:07 Tx date 2022-02-16 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$16,064
+3,150 vol $5.10 each |
32,384 | |
| Filed 2022-02-14 13:40 Tx date 2022-02-11 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,604
+300 vol $5.35 each |
29,234 | |
| Filed 2022-02-14 13:39 Tx date 2022-02-11 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,582
+300 vol $5.28 each |
28,934 | |
| Filed 2022-02-10 01:54 Tx date 2022-02-09 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,609
+300 vol $5.37 each |
28,634 | |
| Filed 2022-02-10 01:53 Tx date 2022-02-09 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,508
+835 vol $5.40 each |
28,334 | |
| Filed 2022-02-10 01:53 Tx date 2022-02-09 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,967
+365 vol $5.39 each |
27,499 | |
| Filed 2022-01-12 00:35 Tx date 2022-01-08 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
$952,800
+120,000 vol $7.94 each |
540,000 | |
| Filed 2022-01-12 00:18 Tx date 2022-01-11 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,497
+1,900 vol $6.05 each |
27,134 | |
| Filed 2021-12-31 17:21 Tx date 2021-12-30 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,647
+300 vol $5.49 each |
25,234 | |
| Filed 2021-12-31 17:20 Tx date 2021-12-30 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,977
+900 vol $5.53 each |
24,034 | |
| Filed 2021-12-31 17:19 Tx date 2021-12-30 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,959
+900 vol $5.51 each |
24,934 | |
| Filed 2021-12-31 17:19 Tx date 2021-12-30 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,647
+300 vol $5.49 each |
||
| Filed 2021-12-31 17:16 Tx date 2021-12-30 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,647
+300 vol $5.49 each |
||
| Filed 2021-12-31 17:15 Tx date 2021-12-30 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,959
+900 vol $5.51 each |
||
| Filed 2021-12-31 17:15 Tx date 2021-12-30 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,977
+900 vol $5.53 each |
||
| Filed 2021-12-29 18:00 Tx date 2021-12-29 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,190
+1,500 vol $5.46 each |
23,134 | |
| Filed 2021-12-29 18:00 Tx date 2021-12-29 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,249
+600 vol $5.42 each |
21,634 | |
| Filed 2021-12-29 17:59 Tx date 2021-12-29 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,635
+300 vol $5.45 each |
21,034 | |
| Filed 2021-12-29 17:57 Tx date 2021-12-29 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,629
+300 vol $5.43 each |
20,734 | |
| Filed 2021-07-14 14:58 Tx date 2021-07-14 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,459
+2,000 vol $5.73 each |
20,434 | |
| Filed 2021-05-12 18:51 Tx date 2021-05-12 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$64,260
+9,000 vol $7.14 each |
18,434 | |
| Filed 2021-01-08 10:23 Tx date 2020-11-23 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures
37 - Stock split or consolidation
|
-$140,000 vol |
$35,000 | |
| Filed 2021-01-08 10:22 Tx date 2020-11-23 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
37 - Stock split or consolidation
|
-1,680,000 vol |
420,000 | |
| Filed 2021-01-08 10:21 Tx date 2020-11-23 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-37,735 vol |
9,434 | |
| Filed 2020-09-02 14:50 Tx date 2020-09-01 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
$1,785,000
+1,050,000 vol $1.70 each |
2,100,000 | |
| Filed 2020-05-20 17:52 Tx date 2020-05-15 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures
16 - Acquisition or disposition under a prospectus exemption
|
$
+$175,000 vol $0.85 each |
$175,000 | |
| Filed 2020-05-19 17:56 Tx date 2018-02-08 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-05-12 12:19 Tx date 2020-05-08 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,870
+3,500 vol $0.82 each |
47,169 | |
| Filed 2020-05-12 12:18 Tx date 2020-05-08 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,640
+2,000 vol $0.82 each |
43,669 | |
| Filed 2020-01-20 13:28 Tx date 2020-01-17 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,670
+9,000 vol $0.63 each |
41,669 | |
| Filed 2019-09-12 13:25 Tx date 2019-09-10 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$273.50
+475 vol $0.58 each |
32,669 | |
| Filed 2019-09-12 13:24 Tx date 2019-09-10 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$863.70
+1,500 vol $0.58 each |
32,194 | |
| Filed 2019-09-12 13:24 Tx date 2019-09-10 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$863.70
+1,500 vol $0.58 each |
30,694 | |
| Filed 2019-09-12 13:23 Tx date 2019-09-10 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,015
+3,500 vol $0.58 each |
29,194 | |
| Filed 2019-07-17 14:43 Tx date 2019-07-17 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$487.00
+1,000 vol $0.487 each |
25,694 | |
| Filed 2019-07-17 14:42 Tx date 2019-07-17 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,013
+4,000 vol $0.50 each |
24,694 | |
| Filed 2019-06-04 15:13 Tx date 2019-06-03 |
$IPA
ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.") |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,087
+4,000 vol $0.52 each |
20,694 | |
| Filed 2019-02-22 Tx date 2019-02-21 |
$IPA
ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.") |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,534
+8,100 vol $0.56 each |
16,694 | |
| Filed 2019-01-18 Tx date 2019-01-10 |
$IPA
ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.") |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,084
+3,594 vol $0.58 each |
3,594 | |
| Filed 2019-01-18 Tx date 2019-01-10 |
$IPA
ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.") |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,320
+4,000 vol $0.58 each |
7,594 | |
| Filed 2019-01-18 Tx date 2019-01-10 |
$IPA
ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.") |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$570.00
+1,000 vol $0.57 each |
8,594 | |
| Filed 2019-01-02 Tx date 2018-12-31 |
$IPA
ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.") |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
$350,000
+350,000 vol $1.00 each |
1,050,000 | |
| Filed 2018-02-16 Tx date 2018-02-08 |
$IPA
ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.") |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-02-16 Tx date 2018-02-08 |
$IPA
ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.") |
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
00 - Opening Balance-Initial SEDI Report
|
700,000 |